Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Dolutegravir-Lamivudine as Dual Therapy in Naive HIV-Infected Patients: A Pilot Study (PADDLE)

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
ViiV Healthcare
Information provided by (Responsible Party):
Pedro Cahn, The Huesped Foundation
ClinicalTrials.gov Identifier:
NCT02211482
First received: August 5, 2014
Last updated: August 21, 2016
Last verified: August 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: February 2017
  Primary Completion Date: March 2016 (Final data collection date for primary outcome measure)